Intravesical Instillation of Bacille Calmette-Guérin for Superficial Bladder Cancer: Cost-Effectiveness Analysis

TNM Classification of Malignant Tumors

Darryl Carter · The American Journal of Surgical Pathology · 1998 · 6.4K citations

Veterinary Medicine, Oncology, Pathology +14

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

Donald L. Lamm, Brent A. Blumenstein, John D. Crissman et al. · The Journal of Urology · 2000 · 1.3K citations

Medicine, Oncology, Urology +11

A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

Donald L. Lamm, Brent A. Blumenstein, E. David Crawford et al. · New England Journal of Medicine · 1991 · 617 citations · Full text

Medicine, Oncology, Urology +13

<b>TNM Classification of Malignant Tumors.</b>5th ed

Richard A. Szucs · Radiology · 1998 · 448 citations

Veterinary Medicine, Oncology, Pathology +10

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.

Harry W. Herr, David M. Schwalb, Zuo‐Feng Zhang et al. · Journal of Clinical Oncology · 1995 · 303 citations

Medicine, Surgery, Urology +17